Endocrine Therapy of Breast Cancer III

Buch | Softcover

VII, 65 Seiten

2011 | 1. Softcover reprint of the original 1st ed. 1989
Springer Berlin (Verlag)
978-3-642-74506-5 (ISBN)

Artikel merken

The European School of Oncology came into existence to respond to a need for information, education and training in the field of the diagnosis and treatment of cancer. There are two main reasons why such an initiative was considered necessary. Firstly, the teaching of oncology requires a rigorously multidiscipli nary approach which is difficult for the Universities to put into practice since their system is mainly disciplinary orientated. Secondly, the rate of technological development that impinges on the diagnosis and treatment of cancer has been so rapid that it is not an easy task for medical faculties to adapt their curricula flexibly. With its residential courses for organ pathologies and the seminars on new techniques (laser, monoclonal antibodies, imaging techniques etc.) or on the principal therapeutic controversies (conservative or mutilating surgery, primary or adjuvant chemotherapy, radiotherapy alone or integrated), it is the ambition of the European School of Oncology to fill a cultural and scientific gap and, thereby, create a bridge between the University and Industry and between these two and daily medical practice. One of the more recent initiatives of ESO has been the institution of permanent study groups, also called task forces, where a limited number of leading experts are invited to meet once a year with the aim of defining the state of the art and possibly reaching a consensus on future developments in specific fields of on cology.

Progression from Steroid Responsive to Unresponsive State in Breast Cancer.- Drug Resistance.- Integration of Quality-of-Life Issues into Clinical Trials of Breast Cancer.- Adjuvant Systemic Therapy for Breast Cancer Patients Without Lymph Node Metastases (N-).- New Developments in the Field of Aromatase Inhibitors.- Resistance to Antioestrogen Therapy: a Challenge for the Future.- New Antioestrogens Without Oestrogenic Activity.

Erscheint lt. Verlag	13.12.2011
Reihe/Serie	ESO Monographs
Zusatzinfo	VII, 65 p. 4 illus.
Verlagsort	Berlin
Sprache	englisch
Maße	210 x 280 mm
Gewicht	219 g
Themenwelt	Medizin / Pharmazie ► Medizinische Fachgebiete ► Gynäkologie / Geburtshilfe
	Medizinische Fachgebiete ► Innere Medizin ► Endokrinologie
	Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie
Schlagworte	Breast Cancer • Cancer • clinical trial • Oncology • quality of life • Radiaton Oncology
ISBN-10	3-642-74506-7 / 3642745067
ISBN-13	978-3-642-74506-5 / 9783642745065
Zustand	Neuware